James Larkin is a Consultant Medical Oncologist specialising in the treatment of patients with cancer of the kidney and cancers of the skin, including melanoma.
James Larkin took a first in Natural Sciences from Cambridge University and undertook clinical training at Oxford University, qualifying in 1996. He underwent general medical training in London and in 2001 won a Medical Research Council Fellowship for a Clinician, carrying out laboratory research at The Institute of Cancer Research (ICR) which led to the award of a PhD. He completed specialist training at The Royal Marsden and was appointed a Consultant in 2008.
His research interests include the individualisation of patient treatment in renal cancer and melanoma, and the combination of novel targeted therapies to treat these diseases.
He is UK Chief Investigator for a number of clinical trials in melanoma and kidney cancer and has been awarded research grants from bodies including Cancer Research UK, Wellcome Trust and the European Framework Programme 7. He is a member of the NCRI Melanoma Clinical Studies Group and Chair of both the NCRI Renal Cancer Clinical Studies Group and the Royal Marsden/ICR Committee for Clinical Research.